Skip to main content

Miromatrix hits clinical milestone on path to scale organ transplants

The successful nature of the transplants demonstrates the efficacy of bioengineered whole organs using the company's technology.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.